Summary
Novo Nordisk is suing Eli Lilly, alleging that its rival used "false and materially misleading" advertisements for its weight-loss and anti-diabetes treatments. The Danish pharmaceutical company claims Eli Lilly intentionally used outdated trial data to make its drugs appear more effective.